FOI release

Freedom of Information request on the adverse reactions reported through the yellow card scheme (FOI 21/986)

Published 17 January 2022

16th September 2021

FOI 21/986

Dear

Thank you for your emails dated 22 and 26 August where you requested the following:

  • I would like to know roughly what percentage of the total adverse reactions to vaccines do get reported to you

  • Total number of vaccine deaths and adverse reactions you have records for the last 20 years

The Medicines and Healthcare products Regulatory Agency (MHRA) has in place a Yellow Card Strategy to promote the scheme and raise awareness amongst healthcare professionals and patients alike. The reporting rate for spontaneous Adverse Drug Reactions (ADR) is variable and can depend on a multitude of factors. The actual rate is unknown and variable because it is influenced by public awareness and seriousness of the event.

The reporting rate for the COVID-19 vaccines will be increased as in addition to social media campaigns, we have issued a Drug Safety Update and a press release informing healthcare professionals and members of the public that reporting to the Coronavirus Yellow Card reporting site. The general public have also been encouraged to report any suspected side effects to the vaccine to the MHRA via a Yellow Card on the televised press briefings. We consider of the variable levels of reporting as part of our monitoring procedures and use statistical analyses which are purposefully designed to minimise the impact of under-reporting.

Please find below Table One showing data for all UK, spontaneous suspected vaccine reports from 01/01/2001 to 05/09/2021 with a data lock point of 08/09/2021. There are columns containing the total number of ADR reports, the total number of reactions and the total number of fatal reports per year. Please note that one ADR report may contain multiple adverse drug reactions. COVID-19 vaccinations have been excluded from this calculation. Information regarding the number of reports for the COVID-19 vaccines can be found in our coronavirus vaccine - weekly summary of Yellow Card reporting.

When looking at Yellow Card data it is important to note that a reported reaction does not necessarily mean it has been caused by the vaccine, only that the reporter had a suspicion it may have. The fact that symptoms occur after use of a vaccine, and are reported via the Yellow Card scheme, does not in itself mean that they are proven to have been caused by the vaccine. Underlying or concurrent illnesses may be responsible and such events can also be coincidental.

It is also important to note that the number of reports received via the Yellow Card scheme does not directly equate to the number of people who suffer adverse reactions and therefore cannot be used to determine the incidence of a reaction. ADR reporting rates are influenced by the seriousness of ADRs, their ease of recognition, the extent of use of a particular drug or vaccine and may be stimulated by promotion and publicity about a drug or vaccine. Reporting tends to be highest for newly introduced medicines during the first one to two years on the market and then falls over time. For these reasons the above data should not be used as a basis for determining incidence of side effects. During assessment we consider of the variable levels of reporting as part of our monitoring procedures.

Table One: Table showing the total number of ADR reports, total number of reactions and total number of fatal reports for all UK, spontaneous vaccine reports received 01/01/2001-05/09/2021 with a data lock point of 08/09/2021.

Year Total numbers of reports Total number of reactions Total number of fatal reports
2001 1497 2980 17
2002 1458 2928 17
2003 2147 4340 16
2004 1835 3662 12
2005 2230 4784 14
2006 1513 3839 9
2007 1315 3547 11
2008 2425 5947 21
2009 5429 14708 31
2010 3753 9503 38
2011 2507 6970 24
2012 1875 6048 15
2013 2899 9328 24
2014 2733 8596 20
2015 3079 10440 26
2016 3394 11053 22
2017 3880 12326 19
2018 3926 12968 25
2019 3360 11215 23
2020 2737 9060 13
01/01/21-05/09/21 2959 10337 6

I hope the information provided is helpful, but if you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of this response; and can be addressed to this email address.

Yours Sincerely,

FOI Team,

Vigilance and Risk Management of Medicines Division